Infliximab in a child with therapy-resistant systemic vasculitis

Treatment of systemic vasculitides is usually based on the use of corticosteroids and other immunosuppressive drugs. We describe a 10-year-old girl with systemic vasculitis resistant to immunosuppressive treatment who had a rapid and impressive response to treatment with infliximab.

Saved in:
Bibliographic Details
Published in:Clinical rheumatology 2006-09, Vol.25 (5), p.769-771
Main Authors: de Kort, Sandra W K, van Rossum, Marion A J, ten Cate, Rebecca
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal - therapeutic use
Antirheumatic Agents - therapeutic use
Child
Female
Humans
Infliximab
Medical research
Polyarteritis Nodosa - drug therapy
Polyarteritis Nodosa - pathology
Remission Induction
Treatment Outcome
Tumor Necrosis Factor-alpha - antagonists & inhibitors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Treatment of systemic vasculitides is usually based on the use of corticosteroids and other immunosuppressive drugs. We describe a 10-year-old girl with systemic vasculitis resistant to immunosuppressive treatment who had a rapid and impressive response to treatment with infliximab.
ISSN:0770-3198
1434-9949
DOI:10.1007/s10067-005-0071-7